Flucytosine Catalog No.:M9399-2 Protective effect of lafutidine

Protective effect of lafutidine

4-tetrahydroquinazoline-6-sulfonamide

KU-60019 treatment (3 μM) blocks basal and insulin-induced AKT S473 phosphorylation by 70% and ~50%

Riboflavin

In primary cultures of rat cerebrocortical neurons

Flucytosine Catalog No.:M9399-2 Protective effect of lafutidineFlucytosine, a fluorinated pyrimidine analogue, is a synthetic antimycotic drug. It is structurally related to the cytostatic fluorouracil and to floxuridine. Oral flucytosine is indicated for the treatment of serious infections caused by susceptible strains of Candida or Cryptococcus neoformans. It can also be used for the treatment of chromomycosis (chromoblastomycosis), if susceptible strains cause the infection. Product information CAS Number: